本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Fulcrum Therapeutics

7.65
-0.2900-3.65%
盤後7.650.00000.00%16:04 EDT
成交量:39.74萬
成交額:308.75萬
市值:4.13億
市盈率:-931.68
高:8.10
開:8.03
低:7.63
收:7.94
資料載入中...
2022/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/10

重要事件披露

8-K - Current report
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/03

重要事件披露

8-K - Current report
2022/03/03

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/10

重要事件披露

8-K - Current report
2022/01/04

重要事件披露

8-K - Current report
2021/11/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/12

重要事件披露

8-K - Current report
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]